4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-065645
Chief Strategy Officer sold 2,274 shares at $5.84 ($13,280)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nayak Sanjay Chief Strategy Officer | 2024-05-23 | Sale 10b5-1 | −2,274 | $5.84 | $13,280 | 178,026 | D |
| Open-market sales · 2,274 sh · avg $5.84 · $13,280 | |||||||
Loading xslF345X05/tm2415610-2_4seq1.xml…